Login / Signup

Expression of the Novel Cardiac Biomarkers sST2, GDF-15, suPAR, and H-FABP in HFpEF Patients Compared to ICM, DCM, and Controls.

Peter JirakRudin PistulliMichael LichtenauerBernhard WernlyVera PaarLukas J MotlochRichard RezarChristian JungUta C HoppeP Christian SchulzeDaniel KretzschmarRüdiger C Braun-DullaeusTarek Bekfani
Published in: Journal of clinical medicine (2020)
Based on their differences in secretion patterns, novel cardiovascular biomarkers might represent a promising diagnostic tool for HFpEF in the future.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • chronic kidney disease
  • ejection fraction
  • binding protein
  • peritoneal dialysis
  • heart failure